Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee Prostheses
Study Details
Study Description
Brief Summary
The purpose of the study is to evaluate the clinical performance of the cruciate ligament retaining or cruciate ligament substituting implants by obtaining a series of primary TKAs. Outcome scoring and radiographic assessment will be the methods used to evaluate performance.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The study will evaluate the clinical performance of cruciate ligament retaining or cruciate ligament substituting implants through a series of primary TKAs. Patients will receive either the P.F.C.® Sigma™ Rotating Platform Cruciate Retaining Knee implant or the P.F.C.® Sigma™ Rotating Platform Cruciate Substituting Knee implant and assignment will be randomized.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: 1 Rotating Platform Cruciate Retaining Knee implant |
Device: Total Knee Replacement
Rotating Platform (RP) Cruciate Retaining Knee implant
Other Names:
|
Active Comparator: 2 Rotating Platform Cruciate Substituting Knee implant. |
Device: Total knee replacement
Rotating Platform (RP) Cruciate Substituting Knee implant.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Knee Society scores [Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
Secondary Outcome Measures
- Complications [On-going to end of study]
- Revisions [On-going to end of study]
- Medical imaging [Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
- SF-12 patient outcomes [Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Osteoarthritis
-
Rheumatoid arthritis
-
Avascular necrosis (AVN) of bone
-
Other inflammatory arthritis
-
Post-traumatic arthritis
-
Juvenile rheumatoid arthritis
Exclusion Criteria:
-
Prior ipsilateral TKA
-
Metabolic disorders
-
Joint replacement due to autoimmune disorders
-
History of recent/active joint sepsis
-
Charcot neuropathy
-
Psycho-social disorders that would limit rehabilitation
-
Greater than 75 years of age at the time of surgery
-
Severe diabetes mellitus
-
Skeletal immaturity
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | La Jolla | California | United States | 92037 | |
2 | West Coast Orthopaedic Specialists | Crystal River | Florida | United States | 34429 |
3 | Melbourne | Florida | United States | 32901 | |
4 | Cleveland Heights | Ohio | United States | 44118 |
Sponsors and Collaborators
- DePuy Orthopaedics
Investigators
- Study Director: Tammy L O'Dell, EMT, CCRA, DePuy Orthopaedics
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- SRP-1